Diffuse venous thromboemboli associated with IVIg therapy in the treatment of streptococcal toxic shock syndrome: Case report and review

Annals of Hematology

Volumn 84, Issue 9, 2005, Pages 601-604

  Geller, Jordan L ^a   Hackner, Dani ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Immunoglobulins (intravenous); Respiratory distress syndrome (adult); Sepsis syndrome; Streptococcus pyogenes; Thromboembolism

Indexed keywords

CLINDAMYCIN; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; OXYGEN; PENICILLIN G; TOXIC SHOCK SYNDROME TOXIN 1;

ABDOMINAL DISTENSION; ADULT; AFRICAN AMERICAN; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BLOOD CULTURE; CASE REPORT; CHILL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ECHOGRAPHY; ERYTHEMA; FEMALE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTOSIS; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG INFILTRATE; MORTALITY; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; PLEURA EFFUSION; PRIORITY JOURNAL; SORE THROAT; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; THORAX RADIOGRAPHY; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PULMONARY EMBOLISM; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; THROMBOEMBOLISM; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS;

EID: 23944434227     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1043-3     Document Type: Article

References (22)

1. A Bisno 1995 Streptococcus pyogenes In: GL Mandell JE Bennett R Dolin (eds.) Principles and practice of infectious diseases Churchill Livingstone New York, NY 1786-1799
2. Musher DM, Hamill RJ, Wright CE et al (1996) Trends in bacteremic infection due to Streptococcus pyogenes (group A streptococcus), 1986-1995. Emerg Infect Dis 2:54-56
3. Schlievert PM (2001) Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related issues. J Allergy Clin Immunol 108:107-110
4. The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. JAMA 269:390-391
5. Barry W, Hudgins L, Donta ST et al (1992) Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267:3315-3316
6. Perez CM, Kubak BM, Cryer HG et al (1997) Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review. Am J Med 102:111-113
7. Alenandria MM, Lansang MA, Dans LF et al (2001) Intravenous immunoglobulin (IVIg) for treating sepsis and septic shock. ACP J Club 135:82
8. Kaul R, McGeer A, Norrby-Teglund A et al (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. Clin Infect Dis 28:800-807
9. Cawley MJ, Briggs M, Haith LR Jr et al (1999) Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: Case report and review. Pharmacotherapy 19:1094-1098
10. Norrby-Teglund A, Heshman B, Anderson J et al (1998) Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: Implications for theurapeutic efficacy. Clin Infec Dis 26:631-638
11. Emerson GG, Herndon CN, Sreih AG (2002) Thrombotic complications after intravenous immunoglobulin therapy in two patients. Pharmacotherapy 22(12):1638-1641 10.1592/phco.22.17.1638.34125
12. Gottlieb S (2002) Intravenous immunoglobulin increases risk of thrombotic events. BMJ 324(7345):1056
13. Vucic S, Chong PS, Dawson KT, Cudkowicz M, Cros D (2004) Thromboembolic complications of intravenous immunoglobulin treatment. Eur Neurol 52(3):141-144
14. Hefer D, Jaloudi M (2004) Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: A case report and discussion of the relevant literature. Ann Hematol 83(10):661-665
15. Zaidan R, Al Moallem M, Wani BA, Shameena AR, Al Tahan AR, Daif AK, Al Rajeh S (2003) Thrombosis complicating high dose intravenous immunoglobulin: Report of three cases and review of the literature. Eur J Neurol 10(4):367-372
16. Wolberg AS, Kon RH, Monroe DM, Hoffman M (2000) Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. Am J Hematol 65(1):30-34 10.1002/1096-8652(200009)65:1<30::AID-AJH5>3.3.CO;2-A
17. Grillo JA, Gorson KC, Ropper AH, Lewis J, Weinstein R (2001) Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Neurology 57(9):1699-1701
18. DC Bjornson JD Grabenstein 2005 Immune globulin In: RK Klasco (ed.) DRUGDEX system Thomson MICROMEDEX Greenwood Village, CO
19. Freeman BD, Buchman TG (2002) Coagulation inhibitors in the treatment of sepsis. Exp Opin Investig Drugs 11(1):69-74
20. Yan SB, Helterbrand JD, Hartman DL (2001) Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120:915-922 10.1378/ chest.120.3.915
21. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
22. Bernard GR, Vinvent J-L, Laterre P-R et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. NEJM 344:699-708